-
A brief intervention of an extract of ginger administered four times daily was effective in ameliorating nausea and vomiting of pregnancy in this small single-blind trial.
-
Upon evaluating data from the STAR*D project, researchers concluded that phase III clinical trials often do not recruit representative populations of depressed outpatients, making the recommendations drawn from the studies' conclusions of limited applicability to general clinical practice.
-
This small pilot study represents the first controlled assessment of intravenous micronutrient therapy for fibromyalgia. No statistically significant benefit over placebo was identified, though clinical benefit was apparent, and feasibility was established. Regardless of one's bias regarding this type of care, further study is needed.
-
In an initial investigation of the potential for information from CAM research to influence clinical practice, a 2007 national survey asked acupuncturists, naturopaths, internists, and rheumatologists about their awareness of CAM clinical trials, ability to interpret research results, and use of research evidence in decision making.
-
A study of thermal spa baths for chronic low back pain revealed some benefits over warm tap water baths. However, multiple hypothesis testing takes away from the confidence clinicians can have regarding the true effect. Nonetheless, all patients improved during and after the treatment period of daily baths.
-
-
When it comes to emergency contraception (EC), placement of a Copper T 380A intrauterine device [(IUD), ParaGard, Duramed Pharmaceuticals, a subsidiary of Barr Pharmaceuticals; Pomona, NY] offers excellent protection against unwanted pregnancy, as well as long-term contraception. What are some of the roadblocks that may hinder its use?
-
The Food and Drug Administration (FDA) has approved two new tests for human papillomavirus (HPV). How does the addition of these tests affect current practice?
-
During his 2008 campaign and in the budget framework that President Obama sent to Congress late in February, he signaled his support for a U-turn in federal policy to prevent pregnancy and sexually transmitted infections (STIs) among American youth.
-
Female-controlled prevention options are set to expand with the Food and Drug Administration (FDA) March 2009 approval of the second generation of the female condom manufactured by the Female Health Co.
